This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Therapy app BetterHelp agrees not to sell consumer data to advertisers, will pay $7.8 million to resolve US FTC claims

By Madeline Hughes ( March 2, 2023, 22:27 GMT | Insight) -- The company that owns therapy app BetterHelp must better protect user information and not provide health data to third-party applications for advertising, according to a consent agreement with the US Federal Trade Commission released today. The agreement resolves FTC allegations of multiple counts of unfairness, failure-to-disclose and misrepresentation in a complaint released today that alleges BetterHelp didn't follow through on the privacy pledge — including a seal signaling Health Insurance Portability and Accountability Act compliance — seen on its app.The company that owns therapy app BetterHelp must better protect user information and not provide health data to third-party applications for advertising, according to a consent agreement with the US Federal Trade Commission released today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login